101 – 110 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Prevention of alcohol-related deaths in middle-aged heavy drinkers
- Contribution to journal › Article
-
Mark
Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins.
- Contribution to journal › Article
- 2001
-
Mark
Effects of immunosuppressive treatment on host responses against intracerebral porcine neural tissue xenografts in rats
- Contribution to journal › Article
-
Mark
A systematic overview of chemotherapy effects in ovarian cancer
- Contribution to journal › Scientific review
- 2000
-
Mark
Quality of well being in patients with fibromyalgia
- Contribution to journal › Article
-
Mark
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
(2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(3). p.8-281
- Contribution to journal › Article
- 1999
-
Mark
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
- Contribution to journal › Article
- 1998
-
Mark
Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement
- Contribution to journal › Article
-
Mark
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
(1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307
- Contribution to journal › Article
-
Mark
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial
- Contribution to journal › Article
